Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-10-28
2000-05-09
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142355, 514326, 544129, 546193, 546222, 546224, A61K 31445, C07D21158, C07D40112
Patent
active
060604859
ABSTRACT:
Described is an arylacetic amide derivative represented by the following formula (1): ##STR1## wherein R.sup.1 represents an aryl group or the like, R.sup.2 and R.sup.3 each independently represents an alkyl group, a cycloalkyl group or the like, and R.sup.4 represents an aralkyl group, an alkyl group or the like; or salt thereof. The compound according to the present invention has both excellent anticholinergic action and calcium antagonism and at the same time has high selectivity to bladder, so that it is useful as a preventive or remedy for urinary disorders.
REFERENCES:
patent: 2816895 (1957-12-01), Ehrhart et al.
patent: 4405627 (1983-09-01), Masi
patent: 4584303 (1986-04-01), Huang
patent: 5066680 (1991-11-01), Shiokawa
patent: 5750540 (1998-05-01), Tsuchiya
Riotte et al. "Studies of the spasmolytic activity of . . . " CA 106:207197, 1987.
Okada et al. "Preparation of N-piperidinyl . . . " CA 126:144121, 1997.
Taniguchi et al. "Agents for the treatment of overactive . . . " CA 122:81073, 1994.
Patent Abstracts of Japan, vol. 097, No. 003, Mar. 31, 1997, JP 08 291141, Nov. 5, 1996.
Chemical Abstracts, vol. 118, No. 23, Jun. 7, 1993, AN 231037, J.M. Wilkes, et al., "Second Messengers in the Gastric Gland: A Focus on Calcium", 1991.
Chemical Abstracts, vol. 115, No. 11, Sep. 16, 1991, AN 106867, A. Leonard, et al., "M3-Subtype Muscarinic Receptor That Controls Intracellular Calcium Release and Inositol Phosphate Accumulation in Gastric Parietal Cells", 1991.
Chemical Abstracts, vol. 122, No. 17, Apr. 24, 1995, AN 205037, M. Toselli, et al., "Muscarine Inhibits High-Threshold Calcium Currents with Two Distinct Modes in Rat Embryonic Hyppocampal Neurons", 1995.
Honda Haruyoshi
Kaihoh Terumitsu
Mizuno Hiroyuki
Okada Tomomi
Sato Susumu
Chang Ceila
SSP Co. Ltd.
LandOfFree
Arylacetic amide derivative or salt thereof, and pharmaceutical does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylacetic amide derivative or salt thereof, and pharmaceutical , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylacetic amide derivative or salt thereof, and pharmaceutical will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1065441